913 USING SHORT-TERM MONOTHERAPY AND IN VITRO DATA TO MAKE EARLY PREDICTIONS OF CLINICAL HCV RESPONSE: EXAMPLES FROM MK-5172, A SECOND GENERATION HCV NS3/4A PROTEASE INHIBITOR

✍ Scribed by R.B. Nachbar; J.A. Stone; A. Petry; B. Poland; L. Caro; L.A. Wenning; A. Khan; J. Palcza; K. Van Dyck; I. Fraser; N. Mobashery; E. O'Mara

• Book ID: 117381120
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 76 KB
• Volume: 56
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/s0168-8278(12)60925-8